Improving sleep to reduce heart and metabolic health risks in people with high blood pressure
Effects of a behavioral sleep extension intervention on cardiometabolic risk factors among patients with elevated BP/hypertension
This study is looking at how getting more sleep can help improve heart and metabolic health for adults with high blood pressure, and it involves using sleep trackers, helpful emails, and phone coaching over a year to support participants in extending their sleep.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-10853108 on NIH RePORTER |
What this research studies
This research investigates how extending sleep duration can positively impact cardiometabolic health, particularly in adults with elevated blood pressure. Participants will engage in a behavioral sleep extension intervention that includes self-monitoring through wearable sleep trackers, educational content delivered via email, and motivational coaching through phone calls. The study will last for 12 months, with an initial intensive intervention phase followed by a maintenance phase and a follow-up period. The primary focus is on measuring changes in sleep duration and blood pressure levels.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who have prehypertension or stage I hypertension.
Not a fit: Patients who do not have elevated blood pressure or those with severe sleep disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective strategies for reducing blood pressure and improving overall cardiometabolic health through better sleep habits.
How similar studies have performed: Previous small studies have shown promising short-term improvements in sleep and cardiometabolic risk factors, indicating potential for success with this approach.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Baron, Kelly Glazer — University of Utah
- Study coordinator: Baron, Kelly Glazer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.